Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Wave Life Sciences (WVE) Other Non Operating Income (2016 - 2025)

Wave Life Sciences (WVE) has disclosed Other Non Operating Income for 11 consecutive years, with $234000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Non Operating Income fell 90.82% year-over-year to $234000.0, compared with a TTM value of $527000.0 through Dec 2025, down 83.69%, and an annual FY2025 reading of $527000.0, down 83.69% over the prior year.
  • Other Non Operating Income was $234000.0 for Q4 2025 at Wave Life Sciences, down from $324000.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $2.5 million in Q4 2024 and bottomed at -$701000.0 in Q3 2022.
  • Average Other Non Operating Income over 5 years is $509050.0, with a median of $330500.0 recorded in 2024.
  • The sharpest move saw Other Non Operating Income skyrocketed 337.8% in 2024, then crashed 355.56% in 2025.
  • Year by year, Other Non Operating Income stood at $1.1 million in 2021, then plummeted by 125.99% to -$290000.0 in 2022, then surged by 300.69% to $582000.0 in 2023, then skyrocketed by 337.8% to $2.5 million in 2024, then plummeted by 90.82% to $234000.0 in 2025.
  • Business Quant data shows Other Non Operating Income for WVE at $234000.0 in Q4 2025, $324000.0 in Q3 2025, and -$82000.0 in Q2 2025.